期刊文献+

嗜铬素A在胃肠胰神经内分泌肿瘤诊断及预后判断中的意义 被引量:1

原文传递
导出
摘要 神经内分泌肿瘤(neuroendocrine neoplasms,NENs)是一组起源于肽能神经元和神经内分泌细胞的异质性肿瘤。既往认为,该病发病率低,但近年来欧美各国的流行病学研究显示,NENs的发病率呈增长趋势,其中肺NENs和胃肠胰NENs(gastroenteropancreatic neuroendocrine neoplasms,GEPNENs)的发病率共计为5.25/100000,较30年前升高近5倍。
出处 《诊断学理论与实践》 2015年第1期79-82,共4页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献32

  • 1Yao JC, Hassan M, Phan A, et al. One hundred years af- ter "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clin Oncol,2008,26(18):3063-3072.
  • 2Capelli P, Fassan M, Scarpa A. Pathology - grading and staging of GEP-NETs [J]. Best Pract Res Clin Gastroen- terol,2012,26(6):705 -717.
  • 3Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, et al. Incidence, patterns of care and prognostic factors for out- come of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)[J]. Ann Oncol,2010,21(9):1794-1803.
  • 4Lawrence B, Gustafsson BI, Chan A, et al. The epidemio- logy of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am,2011,40(1):1-18, vii.
  • 5Ploeckinger U, Kloeppel G, Wiedenmann B, et al. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors[J]. Neuroendocrinology, 2009,90(4):349-363.
  • 6Pape UF, Berndt U, MUller-Nordhom J, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours[J]. Endocr Relat Cancer,2008,15 (4):1083-1097.
  • 7Iacangelo AL, Eiden LE. Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/ sorting factor in the regulated secretory pathway[J]. Regul Pept,1995,58(3 ):65-88.
  • 8Modlin IM, Gustafsson BI, Moss SF, et al. Chromogranin A-biological function and clinical utility in neuro en- docrine tumor disease[J]. Ann Surg Oncol,2010,17(9):2427- 2443.
  • 9Zatelli MC, Torta M, Leon A, et al. Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicen- ter Study[J]. Endocr Relat Cancer,2007,14(2):473-482.
  • 10Glinicki P, Kapuacinska R, Jeske W. The differences in ehromogranin A (CgA) concentrations measured in serum and in plasma by IRMA and ELISA methods[J]. Endokrynol Pol,2010,61(4):346-350.

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部